fluorodeoxyglucose f18 has been researched along with Celiac Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Attencourt, C; Fumery, M; Le Mouel, JP | 1 |
Cardin, AJ; Ma, D; Patel, M | 1 |
Chott, A; Hoffmann, M; Kletter, K; Raderer, M; Vogelsang, H; Zettinig, G | 1 |
Comans, EF; Hadithi, M; Mallant, M; Mulder, CJ; Oudejans, J; van Waesberghe, JH | 1 |
4 other study(ies) available for fluorodeoxyglucose f18 and Celiac Disease
Article | Year |
---|---|
F-FDG-PET and Celiac Disease.
Topics: Celiac Disease; Diet Therapy; Endoscopy, Gastrointestinal; Fluorodeoxyglucose F18; Histocytochemistry; Humans; Male; Middle Aged; Positron-Emission Tomography; Treatment Outcome | 2018 |
Celiac Disease on FDG PET/CT.
Topics: Biological Transport; Biopsy; Celiac Disease; Fluorodeoxyglucose F18; Genotyping Techniques; Humans; Intestine, Small; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2019 |
18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Celiac Disease; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Intestine, Small; Lymphoma, T-Cell; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2003 |
18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease.
Topics: Adult; Aged; Aged, 80 and over; Atrophy; Celiac Disease; Duodenum; Female; Fluorodeoxyglucose F18; Humans; Intestinal Mucosa; Intestinal Neoplasms; Longitudinal Studies; Lymphatic Diseases; Lymphoma, T-Cell; Male; Middle Aged; Positron-Emission Tomography; Radiography, Abdominal; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2006 |